Phreesia Stock Price, News & Analysis

Phreesia announced that Zeeshan Butt, PhD, has been appointed to the National Quality Forum’s Measure Applications Partnership (MAP) Clinician Workgroup for a three-year term. This group influences performance measures for federal public reporting and payment programs. Dr. Butt is a licensed clinical health psychologist specializing in patient-reported outcomes. Phreesia supports over 100 million patient visits annually, offering tools that enhance health outcomes and efficiency in healthcare settings. Its Patient Activation Measure® is recognized for improving clinical results and reducing costs.

Phreesia, Inc. (NYSE: PHR) reported fiscal Q2 2023 results, achieving revenue of $67.9 million, a 33% increase year-over-year, with a total of 2,776 healthcare clients. However, the average revenue per client dipped 7% to $18,248, attributed to faster client growth outpacing revenue gains. Adjusted EBITDA was negative $26 million, worsening from negative $11 million a year ago. The company raised its 2023 revenue outlook to $273-$275 million, indicating 28%-29% growth, and adjusted EBITDA guidance improved but remains negative. Cash equivalents dropped to $240.7 million.

Phreesia, Inc. (NYSE: PHR) will announce its fiscal Q2 2023 financial results after market close on September 7, 2022. A press release detailing the results, accompanied by a quarterly stakeholder letter, will be made available on the company's investor website. Following this, a conference call will commence at 5:00 PM ET to discuss the financial outcomes. Phreesia focuses on enhancing patient intake processes in healthcare through its innovative SaaS platform, promoting patient engagement and operational efficiency.

Summary not available.

Phreesia has released a white paper highlighting how patient expectations of healthcare technology are evolving. Based on a survey of 4,136 patients, it reveals that 84% would book appointments online, while 82% would reschedule similarly. Notably, 64% prefer providers with online check-in options, and 70% are willing to make online payments. The paper indicates a significant demand for digital communication with healthcare providers, as 88% of respondents favor it. Phreesia's insights suggest that enhancing digital capabilities can improve patient satisfaction and retention.

Phreesia, a leader in patient intake solutions, has partnered with Compulink Healthcare Solutions to deliver a bidirectional integration between their systems. This collaboration aims to streamline practice operations, enhance patient collections, and improve overall patient satisfaction. Key features include automated eligibility verification, payment collection, and improved data management. The integration is expected to support practices in maximizing profitability and efficiency, with Phreesia’s systems enhancing patient engagement through personalized experiences.

Phreesia, Inc. (NYSE: PHR) reported fiscal first quarter 2023 results, revealing a 31% revenue growth to $63.4 million compared to $48.3 million last year. The average number of healthcare services clients rose by 33% to 2,526, though average revenue per client fell by 5% to $19,193. Adjusted EBITDA was negative $30.6 million, down from positive $0.1 million in the previous year. The company maintains a fiscal 2023 revenue outlook of $271 million to $275 million, projecting a 27% to 29% growth. Adjusted EBITDA guidance improved, now estimated at negative $126 million to negative $122 million.

KLAS and Phreesia announce a report on patient preferences regarding healthcare technology based on a survey of nearly 13,000 patients. The findings reveal patients' desire for digital tools like online appointment scheduling and telehealth services. Key insights indicate that younger patients value digital access, yet many experience gaps in what is offered by providers. Furthermore, the report emphasizes the importance of patient engagement and the need for healthcare organizations to adapt their services to meet these preferences.

Phreesia has been recognized by Becker’s Healthcare as one of the 150 Top Places to Work in Healthcare for 2022. This accolade highlights the company’s commitment to diversity, employee engagement, and professional growth. CEO Chaim Indig expressed pride in the recognition, emphasizing the company's supportive culture and opportunities for development. Phreesia's internal engagement platform, “Life@Phreesia,” focuses on wellness and community involvement, underlining the company's dedication to fostering a positive work environment.